USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cathay Biotech Inc.

USPTO PatentsView assignee record - 40 granted patents across 14 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cathay ranks #7,994 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 14 technology areas.

#7,994
of 49,997 US assignees by volume
Top 37%
by Innovation Score (39.9/100)
14.5
avg claims per patent
+1033%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7994 · Foreign Corporation #7,994 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 40 grants
  • UPPER-Q #7,994/49,997
  • PHOTO-FINISH Cambridge Internatio…
  • CPC-FOCUS C12P · 14 areas
  • INNOV-THIN 39.9/100
  • CLAIMS-RICH 14.5 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +1033% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cambridge International, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cathay’s 39.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cathay

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cathay's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cathay?

Each dot is one of Cathay’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cathay’s own 14.5 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cathay vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 39.940.040.04040.040.040.1 5101520253035 Granted patents (volume) Avg claims / patent China Iwncomm Co., Ltd. - 40, 17China IwncommCummins Intellectual Property, Inc. - 40, 19.4Cummins Intellect…Cambridge International, Inc. - 40, 13.4Cambridge Interna…Camfil AB - 40, 10.78Camfil ABCboe Exchange, Inc. - 40, 17.8Cboe ExchangeCenter of Human-Centered Interaction for Coexistence - 40, 12.03Center of Human-c…Centre of Excellence in Wireless Technology - 40, 30.98Centre of Excelle…Cephalon LLC - 40, 20.02CephalonCathay Biotech Inc. - 40, 14.53Cathay Biotech
Cathay vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cathay's grants concentrate

Cathay Biotech Inc. is a focused PatentsView assignee: 14 CPC subclasses with 77.5% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2021 (10 grants) versus a trough of 3 in 2019. By volume, Cathay sits between China Iwncomm Co., Ltd. and Cephalon LLC.

Cathay's three-year grant acceleration

From 2019–2021 to 2022–2024, Cathay Biotech Inc. moved from 21 to 16 grants (0.76x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Cathay's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cathay holds 40 patents at rank #7,996, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cathay

By rank, the assignees closest to #7,996 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Cathay's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cathay, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), Cathay ranks #53 of 1,268 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Cathay's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

24681012 2019202020212022202320242025 3
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Cathay Biotech Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 3 7.5%
2020 8 20.0%
2021 10 25.0%
2022 8 20.0%
2023 4 10.0%
2024 4 10.0%
2025partial year 3 7.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cathay Biotech Inc.'s patent record in context - here's where to go next.

  • Cathay Biotech Inc.'s lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 77.5% of its portfolio - see every assignee active in that class. Explore C12P
  • Ranked #7,994 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cathay Biotech Inc. against China Iwncomm Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.